|
Market Closed -
Bombay S.E.
14:02:33 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 47.76 INR | -0.50% |
|
+1.40% | -8.29% |
Company Valuation: Caprolactam Chemicals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 150.9 | 218 | 240.8 | 236.9 | 203.1 | 207.2 |
| Change | - | 44.51% | 10.44% | -1.62% | -14.25% | 2.02% |
| Enterprise Value (EV) 1 | 167.2 | 254.1 | 295.4 | 294.7 | 289.6 | 298.7 |
| Change | - | 52% | 16.24% | -0.24% | -1.72% | 3.13% |
| P/E | 23.2x | -17x | 9.45x | 120x | -28.7x | 11.8x |
| PBR | 3.7x | 7.79x | 4.51x | 4.27x | 4.21x | 3.15x |
| PEG | - | 0x | -0x | -1.3x | 0x | -0x |
| Capitalization / Revenue | 2.39x | 10.5x | 2.45x | 3.41x | 3.01x | 1.96x |
| EV / Revenue | 2.65x | 12.3x | 3x | 4.24x | 4.3x | 2.83x |
| EV / EBITDA | 7.45x | -151x | 6.32x | 12.6x | 19x | 6.72x |
| EV / EBIT | 14.2x | -21.1x | 8.38x | 38.6x | -448x | 10.5x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 1.414 | -2.79 | 5.54 | 0.4291 | -1.541 | 3.829 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 63.09 | 20.69 | 98.42 | 69.57 | 67.4 | 105.6 |
| EBITDA 1 | 22.44 | -1.683 | 46.76 | 23.45 | 15.24 | 44.44 |
| EBIT 1 | 11.79 | -12.03 | 35.23 | 7.624 | -0.647 | 28.54 |
| Net income 1 | 6.506 | -12.82 | 25.48 | 1.974 | -7.087 | 17.61 |
| Net Debt 1 | 16.3 | 36.06 | 54.57 | 57.76 | 86.44 | 91.42 |
| Reference price 2 | 32.80 | 47.40 | 52.35 | 51.50 | 44.16 | 45.05 |
| Nbr of stocks (in thousands) | 4,600 | 4,600 | 4,600 | 4,600 | 4,600 | 4,600 |
| Announcement Date | 02/09/21 | 03/09/22 | 02/09/23 | 29/08/24 | 20/08/25 | 02/09/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 2.29M | ||
| 29.27x | 6.72x | 17.18x | 1.34% | 221B | ||
| 27.52x | 4.27x | 13.75x | 2.12% | 122B | ||
| 28.61x | 3.5x | 17.92x | 1.01% | 77.11B | ||
| 19.06x | 6.13x | 30.46x | 3.6% | 64.73B | ||
| 81.92x | 6.17x | 14.34x | 2.6% | 61.81B | ||
| 61.73x | 1.27x | 8.42x | 6.44% | 36.61B | ||
| 10.99x | 1.17x | 6.34x | 3.02% | 32.17B | ||
| 9.04x | 3.03x | 7.11x | 4.67% | 24.36B | ||
| 43.77x | 5.61x | 29.84x | 1.3% | 24.02B | ||
| Average | 34.66x | 4.21x | 16.15x | 2.9% | 66.37B | |
| Weighted average by Cap. | 33.47x | 5.04x | 16.75x | 2.27% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CAPRO6 Stock
- Valuation Caprolactam Chemicals Limited
Select your edition
All financial news and data tailored to specific country editions
















